KALEORID

Main information

  • Trade name:
  • KALEORID 750 mg prolonged-release tablet
  • Dosage:
  • 750 mg
  • Pharmaceutical form:
  • prolonged-release tablet
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • KALEORID 750 mg prolonged-release tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Potassium chloride
  • Product summary:
  • Previous_names: DUREKAL

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 6489
  • Authorization date:
  • 06-08-2007
  • Last update:
  • 26-07-2018